USFDA conducts inspection at Zydus group’s Unit-2 manufacturing plant at Ankleshwar

24 Jan 2026 Evaluate

United States Food and Drug Administration (USFDA) has conducted an inspection at the Zydus group’s Unit-2 manufacturing plant at Ankleshwar, Gujarat. The inspection was conducted from January 19, 2026 to January 23, 2026 and concluded with 3 observations. There were no data integrity related observations. The company will closely work with the USFDA to address the observations expeditiously.

Zydus Lifesciences (formerly known as Cadila Healthcare), a company limited by shares, incorporated and domiciled in India, operates as an integrated pharmaceutical company with business encompassing the entire value chain in the research, development, production, marketing and distribution of pharmaceutical products.


Zydus Lifesciences Share Price

881.95 -2.90 (-0.33%)
23-Jan-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 881.95
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×